Dicot Pharma AB (STO:DICOT)
Sweden · Delayed Price · Currency is SEK 0.2040
-0.0220 (-9.73%)
At close: Jul 3, 2026
Dicot Pharma AB Market Cap
Dicot Pharma AB has a market cap or net worth of 707.61 million as of July 6, 2026. Its market cap has decreased by -39.59% in one year.
Market Cap
707.61M
Enterprise Value
651.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.20
Market Cap Chart
Since June 20, 2018, Dicot Pharma AB's market cap has increased from 63.22M to 707.61M, an increase of 1,019.34%. That is a compound annual growth rate of 35.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 707.61M | 14.71% |
| Dec 30, 2025 | 616.87M | 43.01% |
| Dec 30, 2024 | 431.35M | 65.92% |
| Dec 29, 2023 | 259.98M | 464.37% |
| Dec 30, 2022 | 46.07M | -35.49% |
| Dec 30, 2021 | 71.41M | 56.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 12.14B |
| Cereno Scientific AB | 1.60B |
| Orexo AB | 846.85M |
| EQL Pharma AB | 704.28M |
| Nanexa AB | 655.99M |
| Enzymatica AB | 568.00M |
| Cinclus Pharma Holding AB | 520.29M |
| Moberg Pharma AB | 444.16M |